Novo Nordisk, World Leader in Diabetes Drugs, Is Set to Rally | Barron's
Novo Nordisk collaborates with University of Virginia Center for Diabetes Technology - Nordic Life Science – the leading Nordic life science news service
Novo Nordisk gets nod for oral diabetes drug
Novo Nordisk | driving change to defeat diabetes
Novo Nordisk scraps Type 1 diabetes drug after phase 2 trial | Fierce Biotech
Novo Nordisk wins FDA green light for 'holy grail' diabetes drug Rybelsus | Fierce Pharma
Diabetes Disease Education for Patients | novoMEDLINK™
US approval for Novo Nordisk's Xultophy/IDegLira as diabetes battle hots up
Novo Nordisk adds e-books to patient support program - MM+M - Medical Marketing and Media
New York City FC Team Up With Novo Nordisk to Promote Diabetes Awareness and Prevention | New York City FC
Novo Nordisk Diabetes and Obesity Award; applications due May 1 | OHSU Research News
Eli Lilly and Co and Novo Nordisk AS Among Leading
Diabetes Disease Education for Patients | novoMEDLINK™
Diabetes Drug's New Weight Loss Formula Fuels Cost-Benefit Debate | Kaiser Health News
Novo Nordisk promotes new GLP-1 receptor agonist to fight diabetes, obesity < Pharma < Article - KBR
Novo Nordisk: Right Product, Right Time, Fair Price (NYSE:NVO) | Seeking Alpha
Diabetes Disease Education for Patients | novoMEDLINK™
Novo Nordisk's insulin pen receives EU approval to treat type 2 diabetes
Novo Nordisk CEO on safety concerns associated with off-label use of diabetes drugs - YouTube
Diabetes and You | Diabetes Education for Patients | novoMEDLINK™
A Novo Nordisk diabetes drug may save lives, but Wall Street shrugs - STAT
